|
"Strategies for Reversing Trauma-Related Coagulopathy"
Date
Tuesday, March 25, 2008
Time
12:00 PM – 1:30 PM
Location
Caesars Palace Hotel
3570 Las Vegas Blvd.
Las Vegas, NV, 89109
(702) 792-9222
Room
Roman Ballroom I & III – Palace Tower Promenade Level – 3rd Floor
2 Easy Ways to Register
Program Overview
Trauma is the third leading cause of death overall and the leading cause of death among those aged 1 to 44 in the United States. Hemorrhage is a major contributor to the dilemma of traumatic injury and its subsequent care. Patients with massive traumatic hemorrhage inevitably develop coagulopathy as a result of hemodilution and consumption of platelets and clotting factors. Hemorrhagic shock is a predictor of poor outcome in the injured patient and often results in death due to complications, such as eventual organ failure and the development of infections, including sepsis.
As a critically injured patient progresses through the phases of trauma care, death from causes unrelated to specific injuries becomes more common. More than 80% of the trauma deaths that occur in the OR do so as a result of hemorrhage. These severe injuries comprise a category known as surgical bleeding and account for about 50% of hypotensive patients.
Trauma care is continuously evolving in an effort to enhance outcomes. Currently, the trend is toward nonoperative management of hemorrhage that was previously considered surgical in nature. The acquired coagulopathy of trauma is an important clinical issue requiring ongoing study and debate.
Learning Objectives
Upon completion of the activity, participants should be better able to:
- Review the epidemiology of traumatic injury and hemorrhage
- Describe the clinical aspects of acute traumatic hemorrhage with clinical coagulopathy
- Explain developing concepts for managing traumatic hemorrhage
- Identify pharmacological interventions to control massive bleeding from traumatic injury
- Choose successful strategies and techniques for reversing coagulopathy from trauma
Target Audience
This activity has been designed to meet the educational needs of Trauma Surgeons and Anesthesiologists and other healthcare practitioners who may treat or diagnosis patients with symptoms associated with traumatic injury and hemorrhage.
Agenda
12:00 PM -12:05 PM
Introduction
Richard P. Dutton, MD, MBA
12:05 PM-12:25 PM
Faculty Presentation:
Blunt Trauma and Traumatic Brain Injury in Civilian Population
Deborah M. Stein, MD, MPH, FACS
12:25 PM-12:45 PM
Faculty Presentation:
Hemorrhagic Shock in Military Personnel with Combat-Related Trauma
John B. Holcomb, MD, FACS
12:45 PM-1:25 PM
“Crossfire” Discussion and Audience Questions
Moderator:
Richard P. Dutton, MD, MBA
Discussants:
John B. Holcomb, MD, FACS
Deborah M. Stein, MD, MPH, FACS
1:25 PM-1:30 PM
Final Thoughts
Richard P. Dutton, MD, MBA
Fee
There is no fee to participate in this educational activity.
Estimated Time to Complete Activity
1.5 hours
Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM), the Cardiovascular & Metabolic Health Foundation, and Educational Concepts in Medicine. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine (PIM) designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. This statement of credit will be mailed to you within 3 weeks.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Chairperson
Richard Dutton, MD, MBA
Associate Professor of Anesthesiology
R Adams Cowley Shock Trauma Center
University of Maryland School of Medicine
Baltimore, Maryland
Faculty
Deborah Stein, MD, MPH, FACS
Medical Director
Neurotrauma Critical Care Unit
R Adams Cowley Shock Trauma Center
Assistant Professor of Surgery
Division of Critical Care/Program in Trauma
University of Maryland School of Medicine
Baltimore, Maryland
John Holcomb, MD, FACS
Commander, US Army Institute of Surgical Research
Trauma Consultant for the Surgeon General
Fort Sam Houston, TX
What Is CMH?
The Cardiovascular & Metabolic Health (CMH) Foundation is a not-for-profit 501(c)(3) organization founded by physicians who are dedicated to promoting cardiovascular and metabolic health by improving patient care. Led by a steering committee of renowned experts on cardiovascular and metabolic health, the Foundation offers balanced, cutting-edge educational initiatives for practitioners to improve their understanding of cardiovascular and metabolic diseases, inform them of the latest treatment recommendations, and offer practical strategies for optimizing the care of patients with these diseases.
Attend this program and earn 1.5 CME credits!
*Not accredited by or affiliated with the American College of Surgeons
|
